Blueshift Biotechnologies Overview

  • Founded
  • 2003
  • Status
  • Acquired/​Merged
  • Employees
  • 11
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $13M
Latest Deal Amount

Blueshift Biotechnologies General Information


Manufacturer of equipment for life science research. The company manufactures and distributes IsoCyte and ToxCount focused on measurement, study, analysis and anisotropy of biological molecules and their contents.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 245 Santa Ana Court
  • Sunnyvale, CA 94085
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Blueshift Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 27-Jun-2008 $13M 0000 Completed Startup
1. Early Stage VC Completed Startup
To view Blueshift Biotechnologies’s complete valuation and funding history, request access »

Blueshift Biotechnologies Patents

Blueshift Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20060003320-A1 Labeling targets with fluorescent dyes, then illuminating with fluorescence inducing light, measuring and analyzing fluorescent light to determine presence of target analytes; fluorescence resonanant energy transfer Granted 02-Jul-2004 0000000000 0

Blueshift Biotechnologies Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Blueshift Biotechnologies Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
YFY Biotech Management Company Corporate Venture Capital Minority 000 0000 000000 0
To view Blueshift Biotechnologies’s complete investors history, request access »